Zhenlong Xingnao Capsule (ZXC) is a Tibetan medicine used to treat ischemic stroke. In this study, we determined the and effects of ZXC on reactive oxygen species (ROS) in a mouse BV-2 microglial cell hypoxia-reoxygenation and rat middle cerebral artery occlusion infarction models. We aimed to clarify the role of ZXC in cerebral ischemia protection; reveal amino acid neurotransmitter changes in the frontal cortex after drug intervention; determine mRNA and protein expression changes in Bcl-2, Bax, caspase-3, P38, and nuclear factor (NF)-кB in the frontal cortex and changes in antioxidant indices in the brain; and elucidate the mechanisms underlying ZXC action. After hypoxia-reoxygenation, ROS levels were significantly increased in BV-2 cells, and their levels decreased after treatment with ZXC. ZXC had protective effects on ischemic/anoxic injury and by downregulating the expressions of caspase-3 and NF-кB mRNA during ischemia and reperfusion and that of p38 and caspase-3 during acute ischemia and reperfusion as well as the steady-state levels of excitatory amino acids/inhibitory amino acids and by improving the total antioxidant capacity and total superoxide dismutase activities during ischemia. These findings provide new molecular evidence for the mechanisms underlying ZXC action.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775503 | PMC |
| http://dx.doi.org/10.3389/fphar.2019.01096 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Anti-cerebral ischemic neuronal injury mechanism of Zhenlong Xingnao capsules: role of the Notch/NF-κB signaling pathway.
Am J Transl Res
July 2023
School of Medicine, Jiangxi University of Technology Nanchang 330098, Jiangxi, China.
Article Synopsis
- The study aimed to explore the protective effects of Zhenlong Xingnao capsules against cerebral ischemia-reperfusion injury (CIRI) and their mechanism through the Notch/NF-κB signaling pathway.
- The research involved a rat model of middle cerebral artery occlusion (MCAO) where various treatment groups were assessed for improvements in learning, memory, and brain health indicators, alongside inflammation and oxidative stress assessment.
- Results indicated that Zhenlong Xingnao capsules significantly enhanced neurological function and reduced harmful protein expressions, suggesting they may aid in neuron recovery post-ischemia, though efficacy was diminished with Jagged1 treatment.
Neuroprotective Effects and Mechanisms of Zhenlong Xingnao Capsule in and Models of Hypoxia.
Front Pharmacol
September 2019
Key Laboratory of Traditional Chinese Medicine for Classical Theory, Ministry of Education, Shandong University of Traditional Chinese Medicine, Ji'nan, China.
Zhenlong Xingnao Capsule (ZXC) is a Tibetan medicine used to treat ischemic stroke. In this study, we determined the and effects of ZXC on reactive oxygen species (ROS) in a mouse BV-2 microglial cell hypoxia-reoxygenation and rat middle cerebral artery occlusion infarction models. We aimed to clarify the role of ZXC in cerebral ischemia protection; reveal amino acid neurotransmitter changes in the frontal cortex after drug intervention; determine mRNA and protein expression changes in Bcl-2, Bax, caspase-3, P38, and nuclear factor (NF)-кB in the frontal cortex and changes in antioxidant indices in the brain; and elucidate the mechanisms underlying ZXC action.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!